Bevacizumab May Be Next Standard of Care for Mesothelioma
Doctors at the 2015 American Society of Clinical Oncology annual meeting suggested adding bevacizumab to traditional chemotherapy regimen for mesothelioma.
Trabectedin shows activity in ATREUS trial in patients with sarcomatoid malignant mesothelioma
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
Trabectedin shows activity in ATREUS trial in patients with sarcomatoid malignant mesothelioma
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
Trabectedin shows activity in ATREUS trial in patients with sarcomatoid malignant mesothelioma
PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.
Genelux announces promising data from two phase I trials of GL-ONC1 in head and neck cancer and mesothelioma
Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today announced that data from two Phase I trials…
Genelux announces promising data from two phase I trials of GL-ONC1 in head and neck cancer and mesothelioma
Genelux Corporation, a clinical-stage biopharmaceutical company focused on the development of vaccinia virus for oncolytic immunotherapy, today announced that data from two Phase I trials…
Smoking a significant predictor of lung cancer recurrence in survivors
In 2015, an estimated 158,040 Americans are expected to die from lung cancer, making it the leading cause of cancer death in this country.
Smoking a significant predictor of lung cancer recurrence in survivors
In 2015, an estimated 158,040 Americans are expected to die from lung cancer, making it the leading cause of cancer death in this country.
Asbestos Victims and Families Decry Congressional Push to Run Out the Clock on Compensation
Contact: Alex Formuzis: 202.667.6982 or alex@ewg.org WASHINGTON, D.C.(May 14, 2015) – In response to today’s congressional action setting up a likely House vote on a bill designed to delay compensating asbestos victims, several prominent victims’ advocates took lawmakers to task for siding with industry instead of public health. The Furthering Asbestos Claim Transparency Act, dubbed […]
New Estimate Finds Asbestos Kills 12,000-15,000 Americans a Year
Contact: Alex Formuzis: 202.667.6982 or alex@ewg.org WASHINGTON, D.C. (May 13, 2015) – A new analysis by EWG Action Fund concludes that up to 15,000 Americans die every year from asbestos-related diseases, significantly more than previous estimates. The findings indicate that 50 years after medical research definitively established that asbestos kills, the government still can’t say for […]
EWG Action Fund Seeks Gov’t Data on Asbestos in Consumer Products
Washington, D.C. (May 12, 2015) – EWG Action Fund today filed Freedom of Information requests with the federal Food and Drug Administration and the U.S. Consumer Product Safety Commission seeking information on undisclosed asbestos contamination in consumer goods. “American asbestos mining stopped years ago, but a mounting body of evidence indicates that asbestos still contaminates some consumer products,” EWG […]
Asbestos Exposure Scares and Violations Common Across U.S.
For Immediate Release: May 7, 2015 Contact: Alex Formuzis: 202.667.6982 or alex@ewg.org Washington, D.C. – Almost every week, somewhere in the U.S., another asbestos problem makes the news – contamination of schools, hospitals, court houses and other public buildings, faulty abatement and removal, workers illegally exposed to deadly airborne fibers, and more. Although many people […]
Canada should ban asbestos use in Canada and globally
To prevent future cases of asbestos-related disease, Canada should institute a time-specific ban on asbestos use in Canada and support a global ban, states a commentary in CMAJ (Canadian Medical…
Canada should ban asbestos use in Canada and globally
To prevent future cases of asbestos-related disease, Canada should institute a time-specific ban on asbestos use in Canada and support a global ban, states a commentary in CMAJ (Canadian Medical…
Rosetta Genomics, Ltd. (ROSG) – Medical Equipment – Deals and Alliances Profile – New Market Report
The company discovers, develops and commercializes next generation diagnostic tests for personalized medicine. It provides testing services such as rosetta cancer origin test, resetta lung cancer test, rosetta kidney cancer test and rosetta mesotheliom…